Fundraise / allotmentMajor developmentFiled on BSE ·

Neogen Chemicals reports Q1 FY27 revenue ₹250 cr, 34% growth and PAT ₹17 cr

Neogen Chemicals · Chemicals & Petrochemicals

Arthneeti Research DeskPublished 1 min read
₹250 CrFundraise / allotment

Key highlights

  • Q1 FY27 consolidated revenue at ₹250 crore, up 34% YoY; PAT at ₹17 crore, up 67% YoY
  • Battery Chemicals expansion: 200 MTPA lithium electrolyte salts commissioned, 1,300 MTPA trial ongoing
  • Total project CAPEX ₹1,795 crore; Dahej Phase 1 (₹428 cr) and Pakhajan Phase 2 (₹1,367 cr) due Feb-Mar 2027

Why it's rated major development: the year-on-year change is 67% (50% or more)

Figures checked against the filing by a second AI read. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Neogen Chemicals

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.